V2555

antibody from NSJ Bioreagents

Targeting: ANPEP CD13, gp150, LAP1, p150, PEPN

Immunocytochemistry (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Antibody Data

Product number

V2555

Provider

NSJ Bioreagents

Product name

CD13 Antibody (Lap1)

Antibody type

Monoclonal

Antigen

KG-1 myeloid cells were used as the immunogen for the CD13 antibody.

Description

Protein G purified antibody

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Antibody clone number

B-F10

Vial size

20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)

Storage

Store the CD13 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

References

Submitted references

13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).

Cui SX, Zhang HL, Xu WF, Qu XJ
European journal of pharmacology 2014 Jul 5;734:50-9

---

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.

Gao JJ, Gao ZH, Zhao CR, Yuan Y, Cui SX, Zhang XF, Cheng YN, Xu WF, Tang W, Qu XJ
Investigational new drugs 2011 Aug;29(4):574-82

---

Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.

Cui SX, Qu XJ, Gao ZH, Zhang YS, Zhang XF, Zhao CR, Xu WF, Li QB, Han JX
Cancer letters 2010 Jun 28;292(2):153-62

---

Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells.

Cervelló I, Gil-Sanchis C, Mas A, Delgado-Rosas F, Martínez-Conejero JA, Galán A, Martínez-Romero A, Martínez S, Navarro I, Ferro J, Horcajadas JA, Esteban FJ, O'Connor JE, Pellicer A, Simón C
PloS one 2010 Jun 24;5(6):e10964

---

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J
Diabetes 2005 Dec;54(12):3427-34

---

Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome.

Ekşioğlu-Demiralp E, Budak-Alpdoğan T, Alpdoğan O, Atalay A, Ratip S, Oz D, Bayik M, Akoğlu T
Leukemia & lymphoma 1999 May;33(5-6):567-72

---

A family with high serum leucine aminopeptidase activity derived from a novel variant CD13.

Kawai M, Hara Y, Kubota T, Shiba K, Hosaki S
Clinical chemistry 1998 Feb;44(2):215-20

---

Scleroderma-derived human fibroblasts retain abnormal phenotypic and functional characteristics following retroviral transduction with the SV40 tsT antigen.

Xu S, Vancheeswaran R, Bou-Gharios G, O'Hare MJ, Olsen I, Abraham D, Black C
Experimental cell research 1995 Oct;220(2):407-14

---

Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia.

Howard MR, Thomas L, Reid MM
Journal of clinical pathology 1994 Nov;47(11):1006-9